The Ordinary
The Ordinary Serum Favorites Set – Hyaluronic Acid 2% + B5, Niacinamide 10% + Zinc 1%, Caffeine Solution 5% – Eye and Face Serums for Hydrating, Brightening & Pore-Minimizing Skin Care
4.6
Targets
drynessdark_spotsPores
Certifications
Cruelty-FreeVegan
Key Ingredients
About this Product
The Ordinary's serum — Serum Favorites Set Formulated with Niacinamide, Hyaluronic Acid, Panthenol. Targets dryness and dark spots.
About The Ordinary
The Ordinary is a DECIEM brand known for transparent, ingredient-focused skincare at accessible prices. Leaping Bunny and PETA certified cruelty-free and 100% vegan. Bestsellers include Niacinamide 10% + Zinc 1%, AHA 30% + BHA 2% Peeling Solution, and Hyaluronic Acid 2% + B5.
Frequently Asked Questions
What is The Ordinary Serum Favorites Set – Hyaluronic Acid 2% + B5, Niacinamide 10% + Zinc 1%, Caffeine Solution 5% – Eye and Face Serums for Hydrating, Brightening & Pore-Minimizing Skin Care good for?▾
The Ordinary Serum Favorites Set – Hyaluronic Acid 2% + B5, Niacinamide 10% + Zinc 1%, Caffeine Solution 5% – Eye and Face Serums for Hydrating, Brightening & Pore-Minimizing Skin Care is formulated for dryness, dark_spots, pores.
Is The Ordinary The Ordinary Serum cruelty-free?▾
Yes — The Ordinary Serum Favorites Set – Hyaluronic Acid 2% + B5, Niacinamide 10% + Zinc 1%, Caffeine Solution 5% – Eye and Face Serums for Hydrating, Brightening & Pore-Minimizing Skin Care is cruelty-free, vegan.
Price History
Similar Products
From the Blog
Routine Guide10 min
Budget Skincare Routine Under ₹1,500: Actives That Actually Work
A complete AM/PM routine featuring clinical-grade actives — niacinamide, salicylic acid, SPF 50, and ceramide moisturiser — all under ₹1,500. No science compromises.
Regulatory Guide8 min
Who Approves Skincare or Beauty Products in India? A Guide to CDSCO
Cosmetics in India don't get a single 'approved' stamp the way medicines do. Here's how CDSCO, State Licensing Authorities, and BIS actually divide up regulation — and how to sanity-check a product yourself.
